CD8A and telomere syndrome: An in-depth analysis of the CD8+ and Th cell composition by multiplex immunohistochemistry (mIHC) in matched samples of biopsy and resected STS tissues allows assessing its treatment-mediated modulation and may pave the way towards the development of novel immunotherapeutic strategies.